SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-10-07
👔
TriSalus Life Sciences, Inc.
@TLSI_InsiderForm 4 Filing: Stevens Jennifer Sells $1K of $TLSI
INSIDER SALE
⚡ MATERIALITY: 3/10
corporate issuer
TriSalus Life Sciences, Inc.
Ticker: $TLSI
Transaction Value
$1K
Price/Share: $4.39
transaction date
2026-10-05
Shares: 316
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Stevens Jennifer, holds the title of Chief Regulatory Officer at TriSalus Life Sciences, Inc..
On 2026-10-05, the insider transacted 316 shares.The shares were transacted at a weighted average price of $4.39 per share, resulting in a total market-relevant value of $1K.
Executive Summary Summary
Stevens Jennifer (Chief Regulatory Officer) sold $1K of $TLSI
Post-Transaction Position: 123,794 shares
SEC Accession No: 0001628280-26-065324 (CIK: 1982621)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.